• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    CM Life Sciences II Inc. filed SEC Form 8-K: Leadership Update

    2/19/26 4:32:06 PM ET
    $CMII
    Blank Checks
    Finance
    Get the next $CMII alert in real time by email
    false 0002088805 0002088805 2026-02-12 2026-02-12 0002088805 CMIIU:UnitsEachConsistingOfOneClassOrdinaryShareAndOnethirdOfOneRedeemableWarrantMember 2026-02-12 2026-02-12 0002088805 CMIIU:ClassOrdinarySharesParValue0.0001PerShareMember 2026-02-12 2026-02-12 0002088805 CMIIU:RedeemableWarrantsEachWholeWarrantExercisableForOneClassOrdinaryShareAtExercisePriceOf11.50PerShareMember 2026-02-12 2026-02-12 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM 8-K

     

    CURRENT REPORT

    PURSUANT TO SECTION 13 OR 15(d)

    OF THE SECURITIES EXCHANGE ACT OF 1934

     

    Date of Report (Date of earliest event reported): February 12, 2026

     

    Columbus Circle Capital Corp II

    (Exact name of registrant as specified in its charter)

     

    Cayman Islands   001-43112   98-1890239
    (State or other jurisdiction
    of incorporation)
      (Commission File Number)   (IRS Employer
    Identification No.)

     

    3 Columbus Circle, 24th Floor
    New York, NY 10019

    (Address of principal executive offices, including zip code)

     

    Registrant’s telephone number, including area code: (646) 792-5600

     

    Not Applicable

    (Former name or former address, if changed since last report)

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class   Trading Symbol(s)   Name of each exchange on which registered
    Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant   CMIIU   The Nasdaq Stock Market LLC
    Class A ordinary shares, par value $0.0001 per share   CMII   The Nasdaq Stock Market LLC
    Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share   CMIIW   The Nasdaq Stock Market LLC

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     

    ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     

    ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     

    ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

     

    Emerging growth company ☒

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     

     

      

    Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

     

    On February 12, 2026, the Board appointed Marc Spiegel to serve as a member of the Audit Committee and the Compensation Committee of the Board, effective immediately. On February 12, 2026, Adam Back resigned from the Board of Directors (the “Board”) of the Company effective immediately. At the time of his resignation, Mr. Back served on the Audit Committee and the Compensation Committee of the Board.

     

    Item 8.01. Other Events.

      

    On February 12, 2026, Columbus Circle Capital Corp II (the “Company”) consummated its initial public offering (“IPO”) of 23,000,000 units (the “Units”), including 3,000,000 Units issued pursuant to the full exercise by the underwriters of their over-allotment option. Each Unit consists of one Class A ordinary share of the Company, par value $0.0001 per share (the “Class A Ordinary Shares”), and one-third of one redeemable warrant of the Company (each whole warrant, a “Warrant”), with each whole Warrant entitling the holder thereof to purchase one Class A Ordinary Share for $11.50 per share. The Units were sold at a price of $10.00 per Unit, generating gross proceeds to the Company of $230,000,000.

     

    Simultaneously with the closing of the IPO, the Company completed the private sale (the “Private Placement”) of an aggregate of 665,000 units (the “Private Placement Units”). 265,000 Private Placement Units were sold to Columbus Circle 2 Sponsor Corporation LLC, the Company’s sponsor, and 400,000 Private Placement Units were sold to Cohen & Company Capital Markets, a division of Cohen & Company Securities, LLC and Clear Street LLC, the representatives of the underwriters in the IPO, in each case at a purchase price of $10.00 per Private Placement Unit, generating gross proceeds to the Company of $6,650,000.

     

    A total of $230,000,000, or $10.00 per Unit, comprised of the net proceeds from the IPO and the sale of the Private Placement Units, was placed in a U.S.-based trust account maintained by Continental Stock Transfer & Trust Company, acting as trustee.

     

    An audited balance sheet as of February 12, 2026 reflecting the receipt of the proceeds from the IPO and the Private Placement has been issued by the Company and is included as Exhibit 99.1 to this Current Report on Form 8-K.

     

     

    Item 9.01 Financial Statements and Exhibits.

     

    (d) Exhibits

     

    Exhibit No.   Description
    99.1   Audited Balance Sheet as of February 12, 2026.
    104   Cover Page Interactive Data File (embedded within the Inline XBRL document).

     

    1

     

     

    SIGNATURE

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

      COLUMBUS CIRCLE CAPITAL CORP II
         
      By: /s/ Gary Quin
        Name:  Gary Quin
        Title: Chief Executive Officer
           
    Dated: February 19, 2026    

     

     

     

    2

     

     

    Get the next $CMII alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CMII

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $CMII
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Columbus Circle 2 Sponsor Corp Llc bought $2,650,000 worth of Class A ordinary shares (265,000 units at $10.00) (SEC Form 4)

    4 - Columbus Circle Capital Corp II (0002088805) (Issuer)

    2/17/26 8:42:53 PM ET
    $CMII
    Blank Checks
    Finance

    $CMII
    SEC Filings

    View All

    SEC Form 10-K filed by Columbus Circle Capital Corp II

    10-K - Columbus Circle Capital Corp II (0002088805) (Filer)

    3/30/26 5:29:42 PM ET
    $CMII
    Blank Checks
    Finance

    CM Life Sciences II Inc. filed SEC Form 8-K: Financial Statements and Exhibits

    8-K - Columbus Circle Capital Corp II (0002088805) (Filer)

    2/26/26 4:55:40 PM ET
    $CMII
    Blank Checks
    Finance

    CM Life Sciences II Inc. filed SEC Form 8-K: Leadership Update

    8-K - Columbus Circle Capital Corp II (0002088805) (Filer)

    2/19/26 4:32:06 PM ET
    $CMII
    Blank Checks
    Finance

    $CMII
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Columbus Circle 2 Sponsor Corp Llc bought $2,650,000 worth of Class A ordinary shares (265,000 units at $10.00) (SEC Form 4)

    4 - Columbus Circle Capital Corp II (0002088805) (Issuer)

    2/17/26 8:42:53 PM ET
    $CMII
    Blank Checks
    Finance

    SEC Form 3 filed by new insider Alsina Gonzalez Alberto

    3 - Columbus Circle Capital Corp II (0002088805) (Issuer)

    2/10/26 9:48:19 PM ET
    $CMII
    Blank Checks
    Finance

    SEC Form 3 filed by new insider Murphy Matthew Joseph

    3 - Columbus Circle Capital Corp II (0002088805) (Issuer)

    2/10/26 9:47:48 PM ET
    $CMII
    Blank Checks
    Finance

    $CMII
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by CM Life Sciences II Inc.

    SC 13G - SomaLogic, Inc. (0001837412) (Subject)

    10/8/21 4:07:06 PM ET
    $CMII
    Blank Checks
    Finance

    SEC Form SC 13G/A filed by CM Life Sciences II Inc. (Amendment)

    SC 13G/A - SomaLogic, Inc. (0001837412) (Subject)

    9/24/21 4:58:16 PM ET
    $CMII
    Blank Checks
    Finance

    SEC Form SC 13D filed by CM Life Sciences II Inc.

    SC 13D - SomaLogic, Inc. (0001837412) (Subject)

    9/15/21 6:20:38 AM ET
    $CMII
    Blank Checks
    Finance